NCI and NCI-supported researchers use crowdsourcing to answer cancer cell drug sensitivities questions
NCI and NCI-supported scientists intended to characterize molecular markers in cancer, which can then be tested against large collections of human samples, such as those of The Cancer Genome Atlas (TCGA), a project by the National Cancer Institute to genomically characterize thousands of human cancers. Now with this massive NCI database, the ongoing challenge is to mine these data to guide drug development and cancer treatment.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.